n.a. (MRX)

pos +0.00
Today's Range: 0.00 - 0.00 | MRX Avg Daily Volume: 0
Last Update: 12/31/69 - 7:00 PM EST
Volume: 0
YTD Performance: 0.00%
Open: $0.00
Previous Close: $0.00
52 Week Range: $0.00 - $0.00
Oustanding Shares: 0
Market Cap: 0
6-Month Chart
TheStreet Ratings Grade for MRX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy
Moderate Buy
Moderate Sell
Strong Sell
Mean Rec. 0.00 0.00 0.00 0.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
MRX Sector Avg. S&P 500
0.00 0.00 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
Revenue 0.00 0.00 0.00
Net Income 0.00 0.00 0.00
EPS 0.00 0.00 0.00
Earnings for MRX:
Revenue 0.00B
Average Earnings Estimates
Qtr (09/12) Qtr (12/12) FY (12/12) FY (12/13)
Average Estimate $0.49 $0.72 $2.35 $2.69
Number of Analysts 10 15 13 16
High Estimate $0.55 $0.80 $2.46 $3.31
Low Estimate $0.42 $0.60 $2.13 $2.16
Prior Year $0.56 $0.56 $2.40 $2.35
Growth Rate (Year over Year) -12.14% 29.40% -2.21% 14.46%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Face it, when you live and breathe stocks, there are no holidays, you have-to look.
Motivated CEOs, innovative products and smart deals count more than macro events.
Aug 13, 2012 | 7:42 AM EDT
Shares of MRX now seen reaching $33, according to Credit Suisse. Estimates also reduced, given the company's new guidance. Underperform...
May 14, 2012 | 8:11 AM EDT
Shares of MRX now seen reaching $49, Jefferies said. Estimates also raised on biggest upside report in recent memory. Buy rating.
Mar 09, 2012 | 7:27 AM EST
MRX was upgraded to Buy, Goldman Sachs said. $43 price target. Company is focused on generating new growth.
Mar 05, 2012 | 8:19 AM EST
MRX estimates raised through 2013, Jefferies said. Zyclara launch is first in three years. Buy rating.
Jan 27, 2012 | 8:00 AM EST
MRX was initiated with a Hold rating, Cantor Fitzgerald said. $34 price target. Company appears to have reached a growth plateau.
Jan 09, 2012 | 7:27 AM EST
MRX was downgraded from Buy to Hold, Canaccord Genuity said. $36 price target. Company lacks near-term catalysts.
That trend will likely continue all week.
Dec 28, 2011 | 7:55 AM EST
MRX estimates lowered through 2015, Goldman Sachs said.  Reflects updated company guidance.  Maintain $38 price target and Ne...

Columnist Conversations

UK-based Manpower Group (MAN) reported better than expected Q3 earnings, at $1.87 versus a $1.72 estimate. ...
Join me for a very exclusive webinar with the amazing Mark Mahaney, from RBC Capital Markets.  Mark is on...
Yelp continues an October breakdown.  The stock is off over 2% today as it extends its drop from the Oct.
Shares of Union Pacific are getting pounded today.  This earnings inspired flush began with a huge breakd...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.